SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-005818
Filing Date
2025-01-15
Accepted
2025-01-15 15:53:14
Documents
62
Period of Report
2024-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q neog-20241130.htm   iXBRL 10-Q 2291773
2 EX-31.1 neog-ex31_1.htm EX-31.1 14734
3 EX-31.2 neog-ex31_2.htm EX-31.2 14530
4 EX-32 neog-ex32.htm EX-32 11548
5 GRAPHIC img193760187_0.jpg GRAPHIC 646845
  Complete submission text file 0000950170-25-005818.txt   10235952

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20241130.xsd EX-101.SCH 1138007
64 EXTRACTED XBRL INSTANCE DOCUMENT neog-20241130_htm.xml XML 1729510
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 25532856
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)